Saturday 17 October 2026
Export PPCB’s income statement to Excel — free account
Propanc Biopharma Inc
PPCB Healthcare Biotechnology
In the quarter to June 2026, EPS fell 99.6%, free cash flow fell 1,637.4% and total debt fell 21.4%, each against the same quarter a year earlier.
0.34
0.00
0.00%
Follow PPCB
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
2.55 | 2.37 | 2.13 | 2.45 |
+8 more quarters Free account |
Net Debt/EBITDA |
0.11 | 0.00 | 0.01 | 0.02 | |
Debt/Assets |
3.61% | 3.25% | 3.56% | 2.92% | |
Debt/Equity |
0.05 | 0.05 | 0.05 | 0.04 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.35 | 0.18 | 0.25 | 0.40 | |
Capex/Depreciation |
0.00 | (0.33) | (7.67) | (25.00) | |
Interest Coverage |
(124.81) | (167.11) | (61.94) | (15.29) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(1.43) | (1.27) | (1.87) | (3.94) | |
Cash per Share |
0.74 | 0.49 | 1.05 | 1.22 | |
Shareholders Equity per Share |
8.37 | 10.96 | 19.56 | 29.11 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
8.37 | 10.96 | 19.56 | 29.11 | |
Free Cash Flow |
(1.60) | (1.14) | (1.00) | (1.94) | |
Working Capital |
5.19 | 4.75 | 4.08 | 5.19 | |
Capital Expenditures |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Current Asset Value |
5.16 | 3.72 | 3.05 | 5.15 | |
| Other line items | |||||
Quick Ratio |
0.25 | 0.13 | 0.16 | 0.17 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.43) | (1.27) | (1.87) | (3.93) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | |
Average Receivables |
0.01 | 0.01 | 0.01 | 0.01 | |
Average Payables |
1.19 | 1.05 | 1.09 | 1.16 | |
Average Assets |
16.21 | 18.43 | 7.60 | 9.02 | |
Average Common Equity |
11.65 | 13.96 | 3.15 | 5.13 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 6 Oct 2026